Please Wait
Applying Filters...
menu
    • menu
    CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Carmustine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/03/2026 Agno Pharma
    U.S.A
    		 Cygen Korea Co., Ltd. 20250822-210-J-2000 Camustin 2025-08-22 Agno Pharma Jiangsu China 68 Dapu Road, Dapu Industrial Zone, Lianyungang Economic & Technology Development Zone, Lianyungang, Jiangsu, China
    31/03/2026 Apothecon Pharmaceuticals
    India
    		 H.O. Pharm Co., Ltd. 20210426-210-J-954 Camustin 2021-04-26 Apothecon Pharmaceuticals Pvt. Limited India PLOT NO 1134, 1135, 1136, 1137, 1143B, 1144 A&B, 1138 A&B, Padra Jambusar Highway, Tal-Padra, Village-Dabhasa, City. Dabhasa-391 440, Dist. Vadodara, Gujarat State, India
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.